Assistant Professor
University of Wisconsin School of Medicine and Public Health
Middleton, Wisconsin, United States
Dr. Michael Pulia is a tenure track, Assistant Professor in the Department of Emergency at the University of Wisconsin (UW) Madison School of Medicine & Public Health. He earned his undergraduate degree from Illinois Wesleyan University with a double major in Chemistry and Political Science. He earned his medical degree from Loyola University Stritch School of Medicine and completed his residency in Emergency Medicine at the University of Illinois-Chicago, serving as a Chief Resident. He completed his graduate work at UW-Madison, including a MS of Clinical Investigation in 2016 and a PhD anticipated in 2022.
Dr. Pulia’s Emergency Care for Infectious Diseases (EC-ID) research program focuses on improving the management of infectious diseases in the emergency department, with an emphasis on systems engineering guided interventions. His work has been supported with funding from both intra and extramural sources, including the Agency for Healthcare Research and Quality and the Wisconsin Partnership Program. Dr. Pulia has over 40 peer reviewed publications, including invited editorials in top tier medical journals such as Pediatrics, Journal of the American Geriatrics Society, Annals of Emergency Medicine and Annals of Internal Medicine. As a nationally recognized expert in the management of resistant bacterial infections, sepsis, skin infections, pneumonia, urinary tract infections and COVID-19, he has been a regularly invited speaker at national and international conferences, including the Society for Academic Emergency Medicine, ID-Week, and the International Symposium on Intensive Care and Emergency Medicine.
From 2014-2019, Dr. Pulia chaired the American Academy of Emergency Medicine’s Antibiotic Stewardship Task Force, representing emergency medicine at the White House One Health Forum and the United Nations Global Antibiotic Resistance Challenge. Since the onset of the pandemic, Dr. Pulia has shifted some of his focus to COVID-19 with multiple publications and ongoing related research projects, including a recent 5-year 2.4 million dollar R01 award from the Agency for Healthcare Research and Quality to study the long term effects of COVID on antibiotic prescribing and bacterial resistance.
I do not have any relevant financial / non-financial relationships with any proprietary interests.